Clinical Trials Browser

Anovulation, Insulin Resistance, Polycystic Ovary Syndrome, Hyperandrogenism, Glucose Intolerance

NCT03819140 2025-11-14

CCOUP

Phase 4 Completed

51 enrolled 15 charts

Polycystic Ovary Syndrome, Hyperandrogenism

NCT07161440 2025-09-08

PCOSLCMS

Completed

56 enrolled

Polycystic Ovary Syndrome, Hyperandrogenism

NCT03229408 2025-06-10

TIN-PCOS-AOD

Phase 2 Completed

60 enrolled 28 charts

Anovulation, Inflammation, Insulin Resistance, Polycystic Ovary Syndrome, Hyperandrogenism

NCT04979377 2025-03-17

Prevalence of Hyperandrogenism in Type 1 Diabetes

Completed

150 enrolled

Diabetes Mellitus, Type 1, Hirsutism, Insulin Resistance, Oligomenorrhea, Polycystic Ovary Syndrome, Hyperandrogenism

NCT01889199 2025-01-10

Androgen Excess as a Cause for Adipogenic Dysfunction in PCOS Women

Phase 2 Completed

23 enrolled 12 charts

Amenorrhea, Anovulation, Hirsutism, Oligomenorrhea, Polycystic Ovary Syndrome, Hyperandrogenism

NCT02460445 2022-07-27

Phlebotomy and Polycystic Ovary Syndrome

Phase NA Completed

37 enrolled

Insulin Resistance, Polycystic Ovary Syndrome, Hyperandrogenism, Metabolic Syndrome, Primary Dysautonomias

NCT04006171 2021-11-05

CNP

Phase NA Completed

90 enrolled 21 charts

Menstruation Disturbances, Polycystic Ovary Syndrome, Hyperandrogenism

NCT04645745 2021-01-14

Myo-inositol, Alpha-Lactalbumin and Folic Acid Treatment in PCOS

Phase NA Completed

36 enrolled

Polycystic Ovary Syndrome, Hyperandrogenism

NCT03152591 2021-01-05

PCOS

Phase 2 Completed

29 enrolled 24 charts

Other

Insulin Resistance, Obesity, Polycystic Ovary Syndrome, Hyperandrogenism, Overweight

NCT01313455 2019-05-31

Adrenal Hyperplasia Among Young People With PCOS

Completed

96 enrolled

Other

Adrenal Hyperplasia, Congenital, Obesity, Oligomenorrhea, Polycystic Ovary Syndrome, Hyperandrogenism

NCT03383484 2017-12-26

Use of Osteopathic Principles for Nonpharmacologic, Therapeutic Interventions in Women With Polycystic Ovary Syndrome

Phase NA Completed

45 enrolled

Polycystic Ovary Syndrome, Hyperandrogenism

NCT00444288 2017-07-02

PCOS Twin Study - Environmental Factors in the Development of Polycystic Ovary Syndrome, Phase 2

Completed

Gynecologic

Anovulation, Ovarian Cysts, Polycystic Ovary Syndrome, Hyperandrogenism

NCT03088046 2017-03-23

Circulating Androgen Levels Are Not Affected by the Administration of Vaginal Micronized Progesterone for Withdrawal Bleeding in Patients With Polycystic Ovarian Syndrome

Phase NA Completed

15 enrolled

Anovulation, Polycystic Ovary Syndrome, Hyperandrogenism

NCT02651636 2016-01-11

Combined Therapy With Myo-inositol and Alpha-Lipoic Acid in PCOS Women

Phase NA Completed

40 enrolled

Polycystic Ovary Syndrome, Hyperandrogenism

NCT02106676 2015-11-25

Androgen Metabolism and Reproductive Outcome

Completed

400 enrolled

Polycystic Ovary Syndrome, Hyperandrogenism

NCT01940666 2013-11-06

Presentations of Hyperandrogenic Phenotypes in Taiwanese Women

Completed

649 enrolled

Cardiovascular Diseases, Insulin Resistance, Polycystic Ovary Syndrome, Hyperandrogenism, Metabolic Syndrome

NCT01526616 2012-02-06

Spironolactone Plus Metformin in Polycystic Ovary Syndrome

Phase NA Completed

56 enrolled

Polycystic Ovary Syndrome, Hyperandrogenism, Metabolic Syndrome

NCT01511822 2012-01-19

Clinical, Metabolic and Endocrine Effects of the Treatment With Drospirenone and Ethinyl Estradiol Alone or in Combination With Myo-inositol in Young Women With Polycystic Ovary Syndrome (PCOS) and Insulin Resistance

Phase 4 Completed

Insulin Resistance, Polycystic Ovary Syndrome, Hyperandrogenism

NCT01355536 2011-05-18

Metabolic and Endocrine Status in Women With Prior Preterm Birth

Completed

262 enrolled

Gynecologic

Diabetes Mellitus, Hirsutism, Hypertension, Obstetric Labor, Premature, Ovarian Cysts, Polycystic Ovary Syndrome, Hyperandrogenism, Premature Birth

NCT00341731 2009-12-01

Environmental Factors in the Development of Polycystic Ovary Syndrome

Completed

Gynecologic

Ovarian Cysts, Polycystic Ovary Syndrome, Hyperandrogenism

NCT00428311 2007-01-31

Effects of Metformin vs Oral Contraceptives on CV Risk Markers in PCOS

Phase 4 Completed

50 enrolled

Hirsutism, Polycystic Ovary Syndrome, Hyperandrogenism

NCT00413179 2006-12-19

The Effect of Metformin Added to Clomiphene Citrate on Pregnancy Rates in Hyperandrogenic, Chronic Oligoovulatory or Anovulatory Women

Phase 3 Completed

56 enrolled

Anovulation, Infertility, Polycystic Ovary Syndrome, Hyperandrogenism

Clinical Trials

INSUPP-PCOS

CCOUP

PCOSLCMS

TIN-PCOS-AOD

Prevalence of Hyperandrogenism in Type 1 Diabetes

Androgen Excess as a Cause for Adipogenic Dysfunction in PCOS Women

Phlebotomy and Polycystic Ovary Syndrome

CNP

Myo-inositol, Alpha-Lactalbumin and Folic Acid Treatment in PCOS

PCOS

Adrenal Hyperplasia Among Young People With PCOS

Use of Osteopathic Principles for Nonpharmacologic, Therapeutic Interventions in Women With Polycystic Ovary Syndrome

PCOS Twin Study - Environmental Factors in the Development of Polycystic Ovary Syndrome, Phase 2

Circulating Androgen Levels Are Not Affected by the Administration of Vaginal Micronized Progesterone for Withdrawal Bleeding in Patients With Polycystic Ovarian Syndrome

Combined Therapy With Myo-inositol and Alpha-Lipoic Acid in PCOS Women

Androgen Metabolism and Reproductive Outcome

Presentations of Hyperandrogenic Phenotypes in Taiwanese Women

Spironolactone Plus Metformin in Polycystic Ovary Syndrome

Clinical, Metabolic and Endocrine Effects of the Treatment With Drospirenone and Ethinyl Estradiol Alone or in Combination With Myo-inositol in Young Women With Polycystic Ovary Syndrome (PCOS) and Insulin Resistance

Metabolic and Endocrine Status in Women With Prior Preterm Birth

Environmental Factors in the Development of Polycystic Ovary Syndrome

Effects of Metformin vs Oral Contraceptives on CV Risk Markers in PCOS

The Effect of Metformin Added to Clomiphene Citrate on Pregnancy Rates in Hyperandrogenic, Chronic Oligoovulatory or Anovulatory Women